Skip to content
Home/Companies/Healthcare/Biosency
Biosency

Biosency

Healthcare·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Biosency?

Biosency is currently owned by Go Capital through Fonds GOCAPITAL Amorçage 2 (2003 vintage), since 2023.

Hand-verified · updated 2026-04-21

Go Capital
Investor
Go Capital
Fonds GOCAPITAL Amorçage 2 · 2003 · VC

Key facts

HQFrance
SectorHealthcare
Websitebiosency.com

More from Fonds GOCAPITAL Amorçage 2

Other portfolio companies in the same fund.

Flexikeg
Flexikeg
Active
IndustrialsFrance· 2022
Healshape
Healshape
Active
HealthcareFrance· 2022
Aurora Cold Plasma Sterilisation
Aurora Cold Plasma Sterilisation
Active
HealthcareFrance· 2021
Kalsiom
Kalsiom
Exited 2025
HealthcareFrance· 2020
Green Impulse
Green Impulse
Active
EnergyFrance· 2019
Turbotech
Turbotech
Exited 2025
IndustrialsFrance· 2018
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Biosency

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Biosency?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Biosency.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue